Select a company


Company Stage

  • Private (seed)
  • Private (post-seed)
  • Quoted


  • Biotech
  • Healthcare
  • Cleantech
  • Technology
  • Other


  • University of Bath
  • University of Bristol
  • University of Cardiff
  • University of Glasgow
  • University of Leeds
  • King's College London
  • Queen Mary, University of London
  • University of Manchester
  • University of Nottingham
  • University of Oxford
  • University of Sheffield
  • University of Southampton
  • University of Surrey
  • Swansea University
  • University of York
  • Other


  • IP Group
  • IP Venture Fund
  • IP Venture Fund II
  • Top 10 Holdings
    by value
Medical Equipment & Supplies

University: Southampton

Company Stage: Private (post-seed)

Capsant Neurotechnologies

Capsant Neurotechnologies is focused on solving problems in the discovery of novel targets and drugs for central nervous system disorders such as stroke, trauma, epilepsy, Parkinson's and Alzheimer's.

The company has a technology platform based on organotypic slice cultures. Capsant's organotypic slices have characteristics similar to the brain in vivo. As a result, the slices can be used to observe normal brain behaviour. They can also be given the characteristics of diseased brains, and this breakthrough has meant that Capsant can use the slices as screens for new drug candidates.

As at 30 June 2014

IP Group holding



Holding represents undiluted beneficial equity interest excluding debt